Fig. 4From: Allogeneic stem-cell transplantation for multiple myeloma: a systematic review and meta-analysis from 2007 to 2017Individual and pooled weighted incidence of treatment-related mortality (TRM) at 100 days (a), 1 year (b), 2 years (c), 3 years (d), and 5 years (e), stratified by transplantation period. Effect size (ES) is odds ratio or relative risk depending on the studyBack to article page